secwatch / observer

8-K filed January 6, 2025, 6:59 PM ET ticker CRDF CIK 0001213037

other material confidence high sentiment neutral materiality 0.20

Cardiff Oncology amends and restates its bylaws effective January 3, 2025

Cardiff Oncology, Inc.

Board of Directors approved Amended and Restated Bylaws on January 3, 2025.
The amended bylaws were filed as Exhibit 3.1 to the Form 8-K.
No change in fiscal year was reported in connection with the amendment.
The company is incorporated in Delaware and trades on Nasdaq under CRDF.

item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Cardiff Oncology, Inc.: The Board of Directors approved Amended and Restated By-laws (effective 2025-01-03).

Change: bylaw amendment
Effective: 2025-01-03

Exact text from the filing

On January 3, 2025, the Board of Directors of Cardiff Oncology, Inc. (the “Company”) approved the Amended and Restated By-laws of the Company.

View on SEC.gov

Browse all governance changes →

Cardiff Oncology, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-002076

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.